CDKN1B Loss Fuels ER Therapy Resistance in Breast Cancer
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and ...
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and ...
In a groundbreaking study poised to redefine breast cancer therapy, researchers have uncovered the remarkable potential of combining ferulic acid, ...
Breast cancer remains one of the leading causes of cancer-related mortality among women globally. Recent studies have identified distinct molecular ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine